Human testing of coronavirus vaccine to begin by September: Johnson & Johnson

A laboratory technician works with a pipette at the Institute of Virology at the Charité Berlin Mitte, where investigations on coronavirus are underway. Christophe Gateau | Getty Images. Sketched by the Pan Pacific Agency.

NEW YORK, Mar 30, 2020, Reuters. Johnson & Johnson said on Monday human testing of its experimental vaccine for the coronavirus would begin by September and that it could be available for emergency use authorization in early 2021, CNBC reported.

J&J also said it had committed more than $1 billion of investment along with U.S. agency Biomedical Advanced Research and Development Authority to co-fund vaccine research.

Share it


Exclusive: Beyond the Covid-19 world's coverage